http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-130788-U
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cbb5ffce9642fc9e93f061835c459b7 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 |
filingDate | 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | UA-130788-U |
titleOfInvention | METHOD OF TREATMENT OF ENDOGENIC INTOXICATION SYNDROME OF PURPLE-SEPTIC GENESIS |
abstract | A method of treating endogenous purulent-septic genesis syndrome involves administering an intensive care complex and administering sorbitol infusion at a rate of 6-7 ml / kg bw intravenously at a rate of 7-8 ml / min. Additionally, infusion of 4.2% solution of L-arginine intravenously drip at an initial speed of 10 drops / min, and after 20 minutes the speed can be increased to 30 drops / min. The total duration of administration of L-arginine 1.5 h. |
priorityDate | 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.